Serencio, Rovelyn V.
HRN: 06-69-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/30/2022
06/05/2022
IVT
500mg
Q6
Amoebiasis
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes